For decades, polycystic ovarian syndrome (PCOS) has been one of the most common hormonal conditions affecting women, impacting an estimated 1 in 10 women of reproductive age worldwide. But in 2026, an international group of researchers, clinicians, and patient advocates announced a major change: PCOS is now being renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS).
At first glance, this may seem like a small change. After all, a new name doesn’t change the symptoms or magically cure the condition. But many experts believe this shift represents an important step forward in how we understand, diagnose, and treat one of the most common hormonal conditions affecting women.
Why Change the Name?
The biggest issue with the term polycystic ovary syndrome is that it has always been somewhat misleading. Many people assume that PCOS is simply a condition involving ovarian cysts. In reality:
- Not everyone with PCOS has polycystic ovaries.
- The “cysts” seen on ultrasound are actually immature follicles, not true cysts.
- The condition affects much more than the ovaries.
Over the years, researchers have learned that PCOS is a complex disorder involving multiple hormone systems, metabolism, insulin regulation, reproduction, and long-term health risks. Many experts felt that the old name failed to capture the true nature of the condition and contributed to confusion among both patients and healthcare providers.
What Does PMOS Mean?
The new name – Polyendocrine Metabolic Ovarian Syndrome – was chosen to better reflect what is happening in the body.
- Polyendocrine recognizes that multiple hormone systems are involved.
- Metabolic highlights the important role of insulin resistance and metabolic health.
- Ovarian acknowledges the reproductive and ovarian features of the condition.
- Syndrome reflects that PMOS is a collection of signs and symptoms that can vary from person to person.
The goal is to shift the conversation away from a condition that appears to be solely about the ovaries and toward one that is understood as a whole-body hormonal and metabolic disorder.
What Does This Mean if You Have Been Diagnosed with PCOS?
If you have previously been diagnosed with PCOS, you do not need to be re-diagnosed, as the diagnostic criteria have not been changed. PMOS is simply the new name for the same condition. Your diagnosis remains valid, and your symptoms, treatment plan, and health risks have not changed because of the terminology update. Think of it as a rebranding that more accurately reflects what researchers and clinicians have learned over the last several decades.
Will the Diagnostic Criteria Change?
For now, the diagnostic criteria remain largely unchanged. Healthcare providers will continue to evaluate the same core features that have historically been used to diagnose PCOS, including:
- Irregular or absent ovulation
- Signs of elevated androgens (such as acne, excess facial hair, or hair thinning)
- Polycystic ovarian morphology on ultrasound
A diagnosis is still based on a combination of these findings after other possible causes have been ruled out. However, many experts hope the new name will encourage healthcare providers to look beyond reproductive symptoms and assess the broader health impacts of the condition.
How Could This Improve Care?
One of the most important aspects of the name change is the increased emphasis on metabolic health. While many people think of PCOS primarily as a fertility condition, it is also associated with:
- Insulin resistance
- Prediabetes and type 2 diabetes
- Elevated cholesterol
- High blood pressure
- Cardiovascular disease risk
- Mental health concerns such as anxiety and depression
By highlighting the metabolic and endocrine aspects of the condition, PMOS may encourage earlier screening and more comprehensive care.
How Could This Change Treatment?
The treatments available today are not changing overnight. Lifestyle interventions, medications, fertility treatments, and symptom management strategies will continue to play an important role. What may change is the way healthcare providers think about treatment. Historically, many patients were offered treatment focused primarily on menstrual cycles, acne, or fertility. The new PMOS framework emphasizes the importance of addressing the underlying hormonal and metabolic drivers of the condition as well. This broader perspective may lead to:
- Earlier screening for insulin resistance
- Increased focus on long-term metabolic health
- More individualized treatment plans
- Greater collaboration between endocrinologists, gynecologists, primary care providers, and other healthcare professionals
Why This Matters
For many patients, the name PCOS never felt like an accurate description of what they were experiencing. Many struggled with symptoms such as fatigue, weight changes, insulin resistance, anxiety, depression, acne, hair loss, and fertility challenges, yet the name focused entirely on the ovaries. Experts have argued that this narrow focus may have contributed to delayed diagnosis, misunderstanding, and fragmented care. The shift to PMOS reflects a growing recognition that this condition is far more complex than its old name suggested.
The Bottom Line
PCOS has officially been renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) to better reflect the hormonal, metabolic, and reproductive features of the condition. For those already diagnosed, the diagnosis itself has not changed. However, the new terminology may help improve awareness, reduce misconceptions, encourage earlier diagnosis, and promote a more comprehensive approach to treatment. Ultimately, the name change is about more than terminology – it’s about recognizing PMOS as the complex, whole-body condition it has always been. If you are seeking an approach to managing your PMOS that takes the whole-body nature of the condition into account, Naturopathic Medicine may be a good fit for you. By focusing on the root cause of symptoms and addressing the whole person (not just the disease), Naturopathic Doctors can tailor treatment to your individual needs. Curious about what this might look like for you? Consider booking a consultation with one of our Naturopathic Doctors today.
Disclaimer: The content provided on this blog is intended for informational purposes only and should not be construed as medical advice. While we strive to present accurate and up-to-date information, the field of naturopathic medicine is continually evolving, and individual health circumstances vary. Therefore, the information herein may not apply to your specific health situation.
Please be aware that engaging with this blog does not establish a doctor-patient relationship. For personalized medical advice, diagnoses, or treatment plans, we recommend scheduling a consultation with a qualified naturopathic physician or other licensed healthcare provider.
In the event of a medical emergency, contact emergency services immediately.
References
Chan, J. L., Masini, I., & Pisarska, M. D. (2026). Polyendocrine metabolic ovarian syndrome (PMOS)/polycystic ovary syndrome (PCOS): Current and future trends. The Journal of Clinical Investigation.
Joham, A. E., Tay, C. T., Laven, J., Louwers, Y. V., & Azziz, R. (2025). Approach to the patient: Diagnostic challenges in the workup for polycystic ovary syndrome. The Journal of Clinical Endocrinology & Metabolism.
McCartney, C. R., & Marshall, J. C. (2016). Polycystic ovary syndrome. The New England Journal of Medicine, 375(1), 54–64. https://doi.org/10.1056/NEJMra1413271
Teede, H. J., Khomami, M. B., Morman, R., et al. (2026). Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: A multistep global consensus process. The Lancet.
Teede, H. J., Moran, L. J., Morman, R., et al. (2025). Polycystic ovary syndrome perspectives from patients and health professionals on clinical features, current name, and renaming: A longitudinal international online survey. EClinicalMedicine.
Teede, H. J., Vanky, E., Piltonen, T. T., et al. (2026). Polyendocrine metabolic ovarian syndrome in pregnancy: Pathophysiology and outcomes. Nature Reviews Endocrinology.
Williams, T., Moore, J. B., & Regehr, J. (2023). Polycystic ovary syndrome: Common questions and answers. American Family Physician, 107(3), 251–258.